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Abstract 
Here for the first time, we investigated the cytotoxic effects of the chitosan extracted 
from the Persian Gulf Chiton shell (Acanthopleura vaillantii) on liver cancer cell line 
(HepG2). Chitosan extraction was implemented following this method: chitin was 
produced by demineralization and deproteinization procedure, and the extracted chitin 
was converted into soluble chitosan using deacetylation method. The cytotoxic effects 
of extracted chitosan were evaluated using four different tests, including 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Annexin V-FITC, 
propidium iodide (PI) staining, 4',6-diamidino-2-phenylindole (DAPI) staining, and 
Caspase activity analysis. The IC50 inhibitory concentrations of chitosan were obtained 
at 250 µg/mL after 24 h. Chitosan clearly inhibited the growth of hepatocarcinoma cells 
in vitro in a dose-dependent manner. For detecting the induced cell apoptosis, HepG2 
cells were treated with 125, 250 and 500 µg/ml of chitosan for 24 h. According to the 
result of Annex in V/PI kit, in 125, 250, and 500 µg/ml of chitosan, 28.2, 49.1, and 
83.3% of HepG2 cells undergone late apoptosis, respectively. The morphology of 
treated cells by DAPI staining showed non uniform plasma membrane and DNA 
fragmentation compared to untreated cells with perfect nucleus. The analysis of cell 
cycle using flow cytometry demonstrated that the rate of sub-G1 peak was increased to 
52.7%. Both caspase-3 and -9 activities increased by the extracted chitosan, but it was 
only significant for caspase-3. The results of the present study suggested that the 
extracted chitosan has efficient cytotoxicity on HepG2 cells. Therefore, the extracted 
chitosan from the shell of the Chiton may be considered as a futuristic natural product 
regarding the treatment of liver cancer. 
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Introduction 
In recent years, oceans and seas have been 
considered as a source of compounds with 
special structure and biological activities 
(Dhinakaran et al., 2012). Marine 
invertebrates (e.g. Mollusca) are one of the 
main groups of marine organisms. 
Nowadays, various ranges of secondary 
metabolites have been extracted from 
marine invertebrates which are extremely 
useful in marine medicines’ production 
(Zoysa, 2012). Often, polyplacophora is 
known as Chiton and a live fossil, because 
they are an ancient group of Mollusca 
(Ávila and Sigwart, 2013). They maintain 
multi-layer shells since million years ago 
(Sigwart, 2009) and have more than 940 
live species. Moreover, about 430 fossil 
specimens have been identified worldwide 
( Stebbins and Eernisse 2009; Weaver et 
al., 2010). The shells include eight 
aragonite segments, which are firmly 
attached to the rocks by the foot and their 
radula is adapted to their way of feeding 
the soft part of their body that is being 
used in the food industry (Connors et al., 
2012).  
    Natural products are secondary 
bioactive metabolites with clear biological 
effects which make them appropriate 
candidates for discovering anti-tumor 
medicine (Hussain et al., 2012). 
Investigation on new medicine seems 
important in cancer treatment, because 
most cancers are resistant to 
chemotherapeutic medicine (Arizza, 
2013). In addition, the high toxicity which 
is usually observed in some cancer 
chemotherapeutic medicines can bring 
about critical side effects. Therefore, the 
demands for new anti-cancer medicines 
derived from natural compounds with the 
lowest toxicity, slightest side-effects, and 
higher therapeutic efficiency are 
increasing (Demain and Vaishnav, 2011). 
The liver as a vital organ plays great roles 
in several contexts, including the whole 
body metabolism activities, important bio-
chemical conversion, energy homeostasis, 
etc., (Mueller et al., 2012). There are 
various liver diseases and they include 
alcoholic liver, fibrosis, cirrhosis, and  
liver cancer (Xu et al., 2010; Ibrahim et 
al., 2011). Today, medical advances in the 
treatment of the liver cancer are not 
enough for prevention or reduction of 
tumor spread. Therefore, the overall 
survival rate of patients with various liver 
cancer has not been reported to be 
significantly improved in the last two 
decades (Gao et al., 2012). Surgery and 
chemotherapy have been known as the 
conventional therapeutic procedures that 
are used despite their high side effects and 
low response rates (Park and Kim, 2010). 
The role of substances derived from 
natural source in reducing malignant 
effects has been improved by recent 
studies. New evidence shows that the 
evaluation of the role of natural substances 
in vivo and in vitro has been increased 
compared to previous years (Skropeta, 
2014). 
    Chitin is a naturally plentiful polymer 
and the second most common 
polysaccharide on earth after cellulose. 
This polymer is hard and consists of a 
linear chain of linked 2-acetoamido-2- 
deoxy-β-D-glucopyranose units (Islam et 
al., 2011; Ocloo et al., 2011)  Chitin is 
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usually found in the shell of crustaceans, 
the cuticles of insects, and the cell walls of 
fungi (Sagheer et al., 2009).  
    Chitosan is derived from deacetylation 
of chitin; it is a linear polysaccharide that 
consists of (1-4)-linked 2-amino-2-deoxy-
b-D-glucopyranose. One of the most 
common applications of chitosan is in 
biomedical and pharmaceutical products 
(Bobu et al. 2011). Chitosan and their 
derivatives have been examined in terms 
of their utility as medicine carriers for anti-
cancer treatment. Biological properties of 
chitosan, including biocompatibility and 
biodegradability depend on the 
deacetylation degree. Chitosan with a 
deacetylation degree of 50 to 60% is a 
suitable issue for lysozyme-catalyzed 
degradation (Kato et al., 2005). Therefore, 
it seems that increasing deacetylation 
degree of chitosan up to 90% is useful for 
anti-cancer applications. The unique 
specifications of the chitosan nanoparticles 
could bring a higher dependency on 
negatively charged biological membranes 
and site-specific targeting in vivo. 
Chitosan nanoparticles have dose-
dependent inhibitory activity on the 
proliferation of various tumor cell lines 
with low toxicity against normal human 
liver cells (Aruna et al., 2013). According 
to various studies, chitin and chitosan have 
been widely applied in medicine and 
pharmaceuticals. They increase the 
persistent motion for the expansion of safe 
and effective drug delivery systems, 
because of their unique physicochemical 
and biological characteristics (Li et al., 
2013). One of the new applications of 
chitosan is the direct use of extracted 
chitosan from various sources on cancer 
cell line, such as extracted chitosan from 
some of the crustacean, insect, and fungi. 
Therefore, in this paper, the cytotoxic 
effect of chitosan extracted from the 
Persian Gulf Chiton shells on liver cancer 
cell line (HepG2) was reported for the first 
time.  This study may hopefully provide 
novel natural resources for chitosan.  
 
Materials and methods 
Extraction of chitin and preparation of 
chitosan 
Chitons (A. vaillantii) were collected from 
the rocky coast of southern Qeshm Island 
of the Persian Gulf and their shells 
(aragonite) were then separated from the 
soft tissues and shipped to the laboratory 
in the wet ice immediately.. Extraction 
process of chitin was divided into 3 steps 
(Fig. 1):  
A: Demineralization was carried out at 
room temperature using 1 M hydrochloric 
acid solution (40 mL/g) for 3 h. 
B: Deproteinization of chitin was carried 
out using 1 M sodium hydroxide solution 
(20 mL/g) at 70°C to obtain chitin. 
C: Deacetylation of chitin was carried out 
by refluxing chitin in 45% sodium 
hydroxide solution (15 mL/g) at 110ºC for 
24 h to obtain chitosan. 
    To solve the chitosan, 2 mL of the 
obtained chitosan was dissolved in 250 µL 
of acetic acid glacial 2%. Then, the 
different doses of chitosan were made for 
cytotoxic tests using serial dilution 
method. 
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Figure 1: Different stages of chitosan preparation. A: Chiton attached to rock in the Persian Gulf. B: 
Identification of Chiton in lab. C: Removal of radula. D: Separation of shells (aragonite). E: 
Powder of aragonite after grinding. F: Demineralization stage. G: Deproteinization stage. H: 
Extracted chitosan. 
 
Materials for cell culture 
HepG2 cancer cells were purchased from 
national cell bank of Iran (NCBI). 
Dulbecco's modified eagle's medium 
(DMEM) were purchased from Bio Idea 
(Iran), Trypsin/EDTA (1X) and fetal 
bovine serum (FBS) were provided by 
GIBCO (USA), penicillin/streptomycin, 
and phosphate buffered saline (PBS) were 
purchased from PAA (Austria). 
AnnexinV-FITC and caspases 3 and 9 kits 
were bought from Abcam (UK), and 3-(4, 
5-dimethylthiozol-2-il) 
2,5dipheniltetrazoliumbromide (MTT) was 
purchased from SIGMA (USA).   
 
Cell culture 
The HepG2 cell line was obtained from 
Pasteur Institute of Iran. Cells were 
cultured in DMEM medium supplemented 
with 10% FBS and 1% 
penicillin/streptomycin, and then 
incubated at 37°C in a humidified 
atmosphere containing 5% CO2. 
MTT assay  
At first, the HepG2 cells were seeded in 
96-well plates and treated with different 
concentrations of chitosan solution for 24 
and 48 h. Then, 5 mg of MTT powder 
mixed with 1 ml PBS was added to the 
wells and incubated at 37°C in the dark for 
4 h and dimethyl sulfoxide (DMSO) was 
added to totally dissolve the formazan 
crystals. The absorbance of each well was 
measured at a wave length of 560 nm with 
a Spectrophotometer (Shen et al., 2009). 
The cell viability inhibition was calculated 
using the following equation:  
Cell viability (%) =Absorbance in test 
wells / Absorbance in control wells × 100 
 
Annexin V-FITC 
The appearance of Phosphatidylserine (PS) 
on the extracellular side of the membrane 
was evaluated using Annexin V/PI 
method. For detection of induced cell 
apoptosis, HepG2 cells were treated with 
125, 250 and 500 µg/mL of chitosan for 24 
A B C D 
E F G H 
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h. Then, the cells were suspended in 500 
µL 1X binding buffer after being treated 
with different concentrations of chitosan 
and centrifuged according to the 
company’s protocol. Then, 5 µL of 
Annexin V-FITC and 5 µL of Propidium 
iodide (PI) were added to centrifuged cells 
and then they were placed at room 
temperature in darkness for five minutes. 
Finally, they were analyzed on flow 
cytometer (Cheng et al., 2012; Guan et al., 
2012). 
 
Analysis of cell cycle by flow cytometry  
To evaluate the effect of the extracted 
chitosan on cell cycle, the HepG2 cells 
were first seeded in 6-well plates and then 
2.5 ml of the respective culture medium 
were added. Next day, the medium was 
replaced by chitosan with concentrations 
of 125, 250 and 500 µg/mL, in 2.5 mL of 
fresh culture medium. An additional 
solution without chitosan was carried out 
as a control group. After 24 h, cells were 
trypsinised and separated from the plate 
and ready for flow cytometry. In general, 
after the cell was collected and washed 
with PBS, 700 µL PI solution was added 
to the wells and incubated at 37ºC for 20 
min in the dark. Then, different 
concentrations of the solution were sorted 
in various micro-tubes and analyzed using 





Apoptotic morphology was monitored in 
DAPI stained cells. The HepG2 cells were 
grown for 24 h on cover slips in 35-mm 
dishes in the presence of 125, 250, and 500 
µg/mL chitosan and absence of chitosan as 
a control group. Cover slips were washed 
twice using PBS fixed with 1000 mL of 
methanol for 5 min and incubated with 10 
μg/mL DAPI for 10 min in the dark. Cells 
were washed with PBS and observed 
under a fluorescent microscope (Lu et al., 
2011). 
 
Caspase activity analysis 
The caspase-3 and caspase-9 were 
significant in the hanging phase of the 
apoptosis. Cells were lysed and then tested 
for protease activity by adding a caspase 
specific peptide that wasconjugated with a 
chromophore p-nitroaniline (pNA). The 
assay was performed using a caspase-3 or 
caspase-9, apoptosis detection, 
Colorimetric Bio Assay Kit (Abcam-UK) 
based on the protocol of the company. 
HepG2 cells (3×105) were treated with 
three concentrations of chitosan, including 
125, 250, and 500 µg/mL for 24 h. The 
control and treated cells were resuspended 
in 50 µL of the cell lysis buffer (supplied 
with the kit) and incubated on ice for 10 
min. Supernatants (cytosolic extract) were 
centrifuged and moved to new tubes and 
kept on ice. The caspase-9 assay was done 
according to the supplied kit protocol. 50 
µL of 2X reaction buffer (containing 10 
mM dithiothreitol [DTT]) was added to 
each sample. Five µL of LEHD-pNA 
substrate (4 mM; 200 µM final 
concentration) was added and incubation 
was done at 37°C for 2 h and thereafter 
absorbance was read at 405 nm 
(Wimardhani et al., 2014). 
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Statistical analysis 
Data analyses were performed using 
Statistical Package for Social Sciences 
(SPSS) 16 software and one-way analysis 
of variance (ANOVA) to determine the 
significance among the groups. All tests 







Monitoring cell morphology 
First observation proved cytotoxic effects 
of the extracted chitosan was changing in 
HepG2 cells morphology as the cells were 
shrunk after being exposed to the chitosan 
solution which showed reduced cell 
volume, plasma membrane distortion, 
nuclear condensation, and apoptotic 
bodies. All these morphological changes 





Figure 2: Effects of chitosan on cytomorphological changes of HepG2 cells. Cancer cell line HepG2 was 
treated with different concentrations of chitosan. A& B: control (without chitosan), C: sham 
(serial diluted method, only acetic acid glacial 2% named "sham" was used alongside the 
control group to study the only effect of extracted chitosan on HepG2), D: 125 µg/mL of 
chitosan, E: 250 µg/mL of chitosan, F: 500 µg/mL of chitosan. 
 
MTT assay 
The second test was MTT assay used to 
evaluate cytotoxic effects of the extracted 
chitosan. HepG2 cells were categorized 
into three groups: the control, sham, and 
treated groups. The half maximal 
inhibitory concentration (IC50) of chitosan 
on HepG2 was calculated using linear 
regression. The IC50 inhibitory 
concentrations of chitosan obtained 250 
µg/mL after 24 h (p<0.05) (Fig. 3). 
Chitosan clearly inhibited the growth of 
hepatocarcinoma cells in vitro in a dose-
dependent manner and showed statistically 
significant differences in inhibition rates.  
A B C
D E F






Figure 3: A: The photo is from MTT assay in 96-well plates. B: Percentages of cell viability HepG2 cell 
line treated with different concentrations of chitosan after 24 and 48 hours using MTT assay. 
The data were represented as mean ± SD. *p<0.05, **p<0.01 and ***p<0.001 were considered 
significant. 
 
Table 1: Percentages of cell viability HepG2 cell line treated with different concentrations of chitosan 
after 24 and 48 hours using MTT assay. The data were represented as mean ± SD. 
Concentration(µg/mL)  Cell viability (%) after 24 h Cell viability (%) after 48 h 
Control 100±0 100±0 
Sham 94±0.017 92±0.025 
31 µg/mL 92±0.015 53±0.041 
62.5 µg/mL 87±0.014 52±0.011 
125 µg/mL 66±0.008 49±0.039 
250 µg/mL 44±0.004 42±0.026 
500 µg/mL 10±0.010 9±0.024 
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Flow cytometry analysis for apoptosis 
detection  
The third test for cytotoxic effects was 
flow cytometry analysis by Annexin V-
FITC. For detection of induced cell 
apoptosis, HepG2 cells were treated with 
125, 250, and 500 µg/mL of chitosan for 
24 h. Then, the cells were stained with 
Annexin V-FITC according to the 
manufacturer’s manual and then analyzed 
using flow cytometry. The apoptosis of 
HepG2 cells induced by chitosan was 
verified through flow cytometry. Early 
apoptosis and late apoptosis/necrosis cells 
were distinguished through Annexin V-
FITC staining. According to the results of 
this study, cells underwent late apoptosis 
in 125, 250 and 500 µg/mL of chitosan, 
28.2, 49.1 and 83.3% of HepG2, 





















































Figure 4: Apoptosis induced by chitosan on HepG2 cells. (A) Control (B) 125µg/mL 
(C) 250 µg/mL (D) 500µg/mL of chitosan conducted by Annexin V/PI assay. 
 
DAPI staining 
The fourth test used in this study to 
evaluate cytotoxic effects of the extracted 
chitosan was DAPI staining. The 
morphological changes of apoptotic cells 
were observed under a fluorescence 
microscope after DAPI staining. Fig. 5 
shows significant morphological changes 
in nuclear chromatin after chitosan 
treatment for 24 h. HepG2 cells treated 
with different concentrations of extracted 
chitosan showed non uniform plasma 
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membrane and DNA fragmentation 
compared to the untreated cells with 
perfect nucleus. Typical apoptotic nucleus 
changes (chromatin condensation, nuclear 
fragmentation) were observed after 
chitosan treatment. It is noteworthy that 
fluorescent staining is a common 
procedure for detection of apoptosis.  
 
Figure 5: Chitosan induced apoptosis in HepG2 cells. Chitosan-treated (experimental group) and –
untreated (control group) cells were stained with DAPI and visualized by fluorescent 
microscopy (magnification: x400). A (control), B (125 µg/mL) C (250 µg/mL) and D (500 
µg/mL) of chitosan conducted by DAPI.  
 
Analysis of cell cycle by flow cytometry  
The fifth test we used for assay cytotoxic 
effects was flow cytometry analysis by PI 
staining. Cell cycle analysis was 
performed to determine cell growth 
inhibition. Cell cycle was divided into four 
stages, consisting of G1, synthesis, G2, 
and mitosis. According to the result of PI 
staining, as shown in Fig 6, the apoptotic 
cells in the sub-G1 area for cells which 
were treated with 250 µg/mL of chitosan 
sub-G1 peak increased remarkably,  
compared with the control. In addition to 
increasing the concentration of chitosan to 
500 µg/ml, the rate of sub-G1 peak  
increased to 52.7%. Therefore, extracted 









Figure 6: Induction of apoptosis on HepG2 cells by extracted chitosan in vitro. Cellular apoptosis was 
verified by flow cytometric analysis. HepG2 Cells were treated with (A) media-only, (B) 125 
µg/mL, (C) 250 µg/mL, and (D) 500 µg/mL of chitosan, respectively. 
 
Caspase activity analysis 
The final test used to assay cytotoxic 
effects of the extracted chitosan was 
caspase activity analysis. The apoptotic 
effect of chitosan was investigated by 
determining caspase-3 and caspase-9 
activity related to different concentrations 
of protein content for cells treated with 
125, 250, and 500 µg/mL of chitosan. The 
obtained results showed that enzyme 
activity increased in a dose-dependent 
manner which was significant only for 
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                       (A) 
 
                        (B) 
Figure 7 (A, B): Effect of treatment with chitosan on caspase-3 and 
caspase-9 activity in HepG2 cells. The data were represented 
as mean ± SD. Significant differences (p<0.05) in caspase-3, 
and caspase-9 activity were found between the treatment and 
control groups. 
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Table 2 (A,B): Effect of the treatment with chitosan on 
caspase-3 and caspase-9 activity in HepG2 
cells. The data were represented as mean ± 
SD. 
Concentration(µg/mL) Caspase-3 activity 
Control 100±0 
125 µg/mL 152±0.036 
250 µg/mL 169±0.020 
500 µg/mL 189±0.045 





125 µg/mL 131±0.037 
250 µg/mL 153±0.041 
500 µg/mL 172±0.030 
                                      (B) 
 
Discussion 
Production of chitosan from the existed 
chitin through nature is important, because 
natural types of chitosan may have novel 
usages in biological science as compared 
to the available commercial chitosan. To 
date, chitin, as a natural polymer, has been 
extracted from different natural resources, 
including crustacean exoskeleton (e.g. 
shrimps and crabs), insect cuticle, squid 
pens, and fungi cell membrane. In this 
research, induction of apoptosis in liver 
cancer cell line using chitosan extracted 
from Chiton shells was investigated. Some 
studies reported that cytotoxicity of 
chitosan is inversely correlated with its 
molecular weight. The low molecular 
weight of chitosan exerted stronger 
cytotoxic effects on all the cancer cells 
than the high molecular weight. For 
example, cytotoxic properties of chitosan 
against oral squamous cell carcinoma 
(SCC) cells varied among the cell lines 
tested; chitosan exerts selective toxicity to 
oral SCC cells and even to the opposite 
effects on non-cancer keratinocytes 
(Wimardani et al., 2012). 
Shen et al. (2009) reported 
chitooligosaccharides extracted from fungi 
inhibited human hepatocellular carcinoma 
(HepG2) cell proliferation. According to 
their result, the growth rate of HepG2 cells 
in response to 1000 µg/mL of 
chitooligosaccharides was 62 and 49% 
after 2 and 3 days, respectively (IC50: 1000 
µg/mL after 72 h) (Shen et al., 2009). 
Thus, the power of induce apoptosis using 
chitosan extracted from Chiton shell is 
more compared to the 
chitooligosaccharides extracted from 
fungi. In another study, Parida et al. 
(2013) reported that the commercial 
chitosan has cytotoxic effect (IC50: 40 
µg/ml) on lymphoma cancer cell lines 
(SUDHL-4)(Parida et al., 2013). Probably, 
this difference is due to the purity of the 
commercial chitosan and chitosan 
extracted from Chiton shells. 
    Guan et al. (2012) reported that 250 
µg/ml N-trimethyl chitosan (TMC) 
significantly induced apoptosis on HepG2. 
Therefore, according to our findings, 
apoptotic effect of the extracted chitosan 
from chiton shell is in line with Guan et 
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al’s. (2012) result. On the other hand, 
Lopez-Heras et al. (2014) in their research 
evaluated the potential of chitosan-
stabilized selenium nanoparticles to induce 
cell cycle arrest and to inhibit in-vitro 
invasiveness in HepG2 cells. According to 
the result of Lopez-Heras et al. (2014), 
flow cytometry (AnnexinV/PI) confirmed 
that the percentage of apoptotic or necrotic 
cell populations in HepG2 cells exposed to 
Chitosan-Stabilized Selenium 
Nanoparticles was not significantly 
different from the control cells ( Lopez-
Heras, 2014). So, it seems that the 
extracted chitosan from shell of Chiton has 
more cytotoxic effects on HepG2 cells as 
compared to those of Chitosan-Stabilized 
Selenium Nanoparticles. 
    Guo et al. (2014) used chitosan and 
derivatives chitosan for anticancer effect 
on HepG2 cells. In the obtained images 
from fluorescence microscopy, chromatin 
condensation and nuclear fragmentation 
are clear (Guo et al., 2014). 
    Shen et al. (2009) reported that 
chitooligosaccharides which were  
extracted from fungi induced cell growth 
inhibition in HepG2 cells. HepG2 cells 
cultured in 10% FBS medium were treated 
with 250 to 1000 µg/mL of 
chitooligosaccharides for 48 h (Shen et al., 
2009). The result of Shen et al. (2009) 
showed that chitooligosaccharides 
treatment significantly inhibited the 
percentage of S-phase cells among the 
HepG2 cells. In another study, Liu et al. 
(2010) reported that TMC-encapsulated 
camptothecin (CPT) induced apoptosis in 
B16-F10 mouse melanoma cell lines. After 
the treatment, PI staining was performed. 
The result showed that camptothecin-
encapsulated with N-trimethyl chitosan 
(CPT-TMC) efficiently inhibited B16-F10 
cells proliferation and increased apoptosis 
in vitro (Liu et al., 2010). Thus, our 
finding conformed more compared to that 
of Shen et al. (2009) and Liu et al. (2010). 
    Apoptosis is coordinated by a family of 
cysteine proteases known as caspases. The 
basic effectors of apoptosis in fold 
proteases from the caspase family were 
inhabited as hidden precursors in most 
nucleated animal cells. According to the 
previous study on caspase, mammalians 
contain fourteen caspase, such as caspase 3 
and caspase 9. Identification pathways of 
caspase-3 activity have been performed 
which is relevant or irrelevant release of 
mitochondrial cytochrome c and caspase-9 
function. Caspase-3 activation is the sign 
of apoptosis, and is essential for apoptotic 
chromatin condensation and DNA 
fragmentation in all the cells (Namvar et 
al., 2014). Wimardhani et al. (2014) 
reported 800 µg/mL of low molecular 
weight chitosan (LMWC) induced 
apoptosis on oral cancer cell line. The 
measurement of caspase 3, caspase 8, and 
caspase 9 activity was performed after the 
treatment by LMWC. LMWC increased 
the activities of caspase-3, caspase-8, and 
caspase-9, although these increases were 
not significant (Wimardhani et al., 2014). 
Therefore, the result of the activity of 
caspase-3 and caspase-9 was 
approximately similar to that of 
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